Menu
Not yet recruiting NCT06976905

Myoma Screw in Manipulation of Large Uterus in Total Laparoscopic Hysterectomy

No phase Interventional Total Laparoscopic Hysterectomy With Myoma Screw

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Total laparoscopic hysterectomy.
Who it may be relevant to
Registry conditions: Total Laparoscopic Hysterectomy With Myoma Screw. Basic parameters: 30 years — 60 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

To compare between myoma screw and uterine manipulator in manipulation of large uterus in total laparoscopic hysterectomy

Detailed description

Hysterectomy is performed on 1,500,000 women worldwide each year to treat benign disorders such leiomyoma, prolapse, and irregular bleeding, as well as gynecologic malignancies. Prior to the introduction of the first laparoscopic procedures in the late 1980s, hysterectomy was traditionally accomplished by laparotomy or the vaginal route. Total laparoscopic hysterectomy (TLH) became the most commonly used hysterectomy technique in the last ten years, especially in developed nations, because laparoscopic hysterectomy has some advantages over other hysterectomy types, including high patient satisfaction, an earlier return to work, less blood loss, the ability to diagnose and treat other pelvic diseases, and the ability to maintain thorough intraperitoneal haemostasis.

However, there are some drawbacks to TLH as well, such as its expensive cost, lengthier operating time, and requirement for advanced technological instruments including uterine manipulators (UM) and sealing devices.

In order to facilitate colpotomy by defining the cervicovaginal junction and enable safer dissection around the cervix, the main goal of utilising a UM is to extend the distance between the cervix and ureter.There isn't enough clinical data in the literature to say whether using UM meets these expectations, though.Additionally, the use of UMs has been linked to a number of specific problems, such as uterine rupture, intestinal perforation, and vaginal wall laceration.UMs are also not appropriate in certain cases, such as vaginal stenosis, anatomical differences that make it difficult to identify the uterus or cervix, and patients who refuse vaginal penetration because they are virgins. There is still no "optimal UM" that is consistently safe, effective, and economical, despite the fact that numerous UMs have been developed in recent decades.

Some studies have suggested alternatives including the use of certain sutures, gripping forceps, or myoma screws (MS) as answers to the issues that arise with the use of UM. When performing a myomectomy using the vaginal method, laparotomy, or laparoscopy, the MS is a conventional, reusable instrument. MSs are renowned for their ability to deliver a powerful three-dimensional traction force. Additionally, using MS does not require specialised knowledge like UMs do.

Interventions

  • Procedure Total laparoscopic hysterectomy
    Hysterectomy by laparoscope using uterine manipulator or myoma screw as a manipulator of large uterus

Primary outcome measures

  • Comparison between Magneshkar uterine manipulator and myoma screw in operation time in hours [Time frame: During surgery in hours]
Secondary outcome measures (1)
  • Volume of blood loss in ml liters [Time frame: Day 1]

Eligibility criteria

Inclusion criteria

  • Age 30-60
  • BMI 25-40
  • Large uterus with fundal level 12-24w diagnosed by TAS( Transabdominal Ultrasound)/TVUS(Transvaginal ultrasound)
  • Adenomyosis

Exclusion criteria

  • BMI more than 40
  • patients with contraindication for laparscopic surgery e.g cardiac and cirrhotic patients

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Quadruple blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Kafrelsheikh University — Kafr ash Shaykh

Identifiers

NCT: NCT06976905 · KFSIRB200-545

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗